Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$32,148,155
+$31,926,595 QoQ
Shares Held
271,958
+23882.2% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 98.012560763059.ToString("F0")%
Shared 0.ToString("F0")%
None 1.9874392369409983.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RENAISSANCE GROUP LLC holds $74,198,538 across 4 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (43.3% of the industry book) .
All Filings in ZTS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,148,155 | 271,958 | Shares | Defined | 2026-05-13 | |
| 2024-09-30 | $221,560 | 1,134 | Shares | Defined | 2024-11-12 | |
| 2023-12-31 | $223,817 | 1,134 | Shares | Defined | 2024-02-09 | |
| 2022-12-31 | $244,445 | 1,668 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $288,127 | 1,943 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,822,403 | 156,044 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $29,863,603 | 158,352 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $38,996,482 | 159,802 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $32,745,593 | 168,670 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $31,970,989 | 171,555 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $27,964,511 | 177,575 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $29,757,065 | 179,801 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $31,278,081 | 189,140 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $27,235,466 | 198,741 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $24,339,351 | 206,809 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||